High flow nasal oxygen therapy is rapidly establishing itself as a low cost, low side effect treatment option in respiratory failure.

In this, another great podcast from the 22nd Annual Meeting of the Australia-New Zealand Intensive Care Society (ANZICS) Clinical Trials Group in Noosa, Australia, Todd is joined by Dr Ed Litton to talk about the upcoming NOTACS trial, an international study exploring its role in preventing complications post cardiothoracic surgery.

<p>High flow nasal oxygen therapy is rapidly establishing itself as a low cost, low side effect treatment option in respiratory failure.</p>
<p>In this, another great podcast from the 22nd Annual Meeting of the Australia-New Zealand Intensive Care Society (ANZICS) Clinical Trials Group in Noosa, Australia, Todd is joined by Dr Ed Litton to talk about the upcoming NOTACS trial, an international study exploring its role in preventing complications post cardiothoracic surgery.</p>

This podcast is dedicated to the hard-working doctors, nurses and allied health professionals striving for excellence

Osler Podcasts

This podcast is dedicated to the hard working doctors, nurses and allied health professionals who are continually striving for excellence in critical care.